Skip to main content
. 2024 Sep 13;13(9):881. doi: 10.3390/antibiotics13090881

Figure 1.

Figure 1

Growth profiles of bacteria, i.e., E. coli (A), P. aeruginosa (B), S. aureus (C) and fungi, i.e., A. brasiliensis (D) and C. albicans (E), in body milk formulation in the presence of the peptides (2–10 kDa) at the MIC value and 0.3% (v/v) of Microcare® BNA (0.3% B), and the association of both (0.3% B+2–10 kDa). A positive control with 0.6% (v/v) of Microcare® BNA and 1% (v/v) of Microcare® SB, an ethanol control, and the formulation without any preservative (negative control) were also performed.